Outline
Mission: to “realize the application of human iPSC-derived cardiomyocytes, hepatocytes and neurons for drug safety evaluations by both technological advancement and including policy recommendations.”
Organizational structure
An Executive Committee
| Consortium Leader | Norimasa Miyamoto, Ph.D. (Eisai Co., Ltd.) |
|---|---|
| Cardiomyocyte Team Leader | Kiyosi Takasuna, Ph.D. (Daiichisankyo Co., Ltd.) |
| Hepatocyte Team Leader | Tomoaki Inoue, Ph.D. (Chugai Pharmaceutical Co., Ltd.) |
| Neuron Team Leader | Takafumi Shirakawa, Ph.D. (Astellas Pharma Inc.) |
| Cell Characterization Team Leader | Tadahiro Shinozawa, Ph.D. (Takeda Pharmaceutical Co., Ltd.) |
| 3D Model Team Leader | Tesuro Araki, Ph., D. (Asahi Kasei Pharma Corp.) |
« Back
